Holoprosencephaly and the teratogenicity of anticonvulsants.
Holmes
L B
LB
Harvey
E A
EA
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000453:epidemiology; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005145:Face / Q000002:abnormalities; D005260:Female; D005385:Fingers / Q000002:abnormalities; D016142:Holoprosencephaly / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D008404:Massachusetts / Q000453:epidemiology; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D010865:Pilot Projects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy
D000927:Anticonvulsants; D010672:Phenytoin